Martinet, D.

patient tumor gbm-o glioblastoma fication oligodendroglioma-like component survival mutation study prognostic feature component neuropathol group treatment necrosis outcome idh 1 mutations signi presence cancer trial value table subtype analysis mgmt methylation status glioma diagnosis classi classi fication pathology survival group signi ficantly review lausanne university hospital identi effect lausanne treatment effect expression oncol idh 1 bene fit month firmed temozolomide ampli factor status department tissue sample criteria anaplastic methylation pattern alteration ficant egfr ampli fication information giant cell gbm frequency egfr ampli fications number grade eortc university association prognostic signi ficance phase firmed gbm radiotherapy van den oligodendroglial analyses prognostic value switzerland brain population